Recent research on obese children in Sweden indicates that integrating liraglutide injections with lifestyle modifications leads to better weight loss outcomes. About 25% of children treated in 2023 received this medication alongside intensive health behavior treatment, resulting in improved health metrics for nearly a third of those on the drug. The benefits go beyond weight loss, reducing family conflict around mealtimes. Future treatments with semaglutide may further enhance results, suggesting a promising direction for pediatric obesity management in coming years.
"Clinicians treating very obese children in Sweden found that liraglutide injections combined with lifestyle changes resulted in a significant weight loss success rate, avoiding mealtime conflicts."
"Dr. Annika Janson stated that the combination of GLP-1 receptor agonists with behavioral treatment could improve children's weight management in the coming years, showing promising outcomes for obesity treatment."
Collection
[
|
...
]